IL-6 antibody, combined with PD-1/PD-L1 antibody treatment, has achieved significant results in animal tumor treatment model.16 Therefore, IL-6 may affect the adjuvant therapeutic effect of PD-1/PD-L1 through an unknown mechanism. The gene discussed is IL6; the disease is neoplasm.